Geron Company
Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, an innovative therapeutic
Technology:
Neuropharmacology
Industry:
Small & Large Molecules
Headquarters:
California, United States
Founded Date:
1990
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
2
Total Funding:
96700000
Estimated Revenue:
Less than $1M
Last Funding Date:
01 01 20
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership